Quality of life after laparoscopy-assisted Billroth I gastrectomy
Quality of life after laparoscopy-assisted Billroth I gastrectomy
复制标题
DOI：
10.1097/00000658-199901000-00006
复制
发表时间：
1999-01-01
影响因子：
9
通讯作者：
Akazawa, K
中科院分区：
文献类型：
--
作者：
Adachi, Y;Suematsu, T;Akazawa, K
目的评价腹腔镜辅助Billroth I型胃切除术(LAG)治疗癌症患者的生活质量。摘要背景资料1994年，作者报道了首例早期胃癌LAG病例，并迅速被日本外科医生采用。方法采用24项问卷，以1、2、3为评分标准，对41例LAG患者和35例常规开腹胃切除术患者的生活质量进行比较。结果LAG患者饮食正常(100%)，每餐摄入量为66%(90%)，功能状态无下降(90%)，手术效果满意(88%)。LAG患者在体重减轻、吞咽困难、烧心和打嗝、早期倾倒综合征和总分等方面明显好于开腹胃切除术。结论采用腹腔镜术的患者术后生活质量明显好于传统术式的患者。LAG，侵袭性更小，更容易被患者接受，是治疗早期胃癌的首选方法。
Objective To evaluate the quality of life of patients who had undergone laparoscopy-assisted Billroth I gastrectomy (LAG) for cure of cancer.Summary Background Data In 1994, the authors reported the first case of LAG for early gastric cancer, and this approach quickly has been adopted by Japanese surgeons. However, little is known about the subjective clinical results of this less invasive surgery.Methods Quality of life was estimated using the 24-item questionnaire with a scoring system of 1, 2, and 3 and was compared between 41 consecutive patients with LAG and 35 with conventional open gastrectomy. All patients underwent Billroth I gastrectomy for early gastric cancer from January 1993 to July 1997 and were alive without recurrence.Results Patients who had undergone LAG were taking a normal diet (100%) with >66% of volume at each meal (90%), showed no decreased performance status (90%), and were satisfied with their surgical results (88%). Patients with LAG, when compared with open gastrectomy, showed significantly better results with regard to weight loss, difficulty in swallowing, heartburn and belch, early dumping syndrome, and total score. LAG was better accepted by the patients.Conclusions Quality of life after Billroth I gastrectomy was significantly better in patients in whom a laparoscopic technique was used than in those who underwent a conventional method. LAG, is less invasive and better accepted by patients and is the procedure of choice for the treatment of early gastric cancer.